Streamline Health Solutions, Inc. (STRM)
NASDAQ: STRM · Real-Time Price · USD
5.18
+0.01 (0.19%)
At close: Jun 27, 2025, 4:00 PM
5.19
+0.01 (0.19%)
After-hours: Jun 27, 2025, 4:04 PM EDT
STRM Market Cap
STRM has a market cap or net worth of $21.43 million as of June 27, 2025. Its market cap has decreased by -48.72% in one year.
Market Cap
21.43M
Enterprise Value
33.96M
1-Year Change
-48.72%
Ranking
Category
Stock Price
$5.18
Market Cap Chart
Since December 1, 1998, STRM's market cap has increased from $9.90M to $21.43M, an increase of 116.50%. That is a compound annual growth rate of 2.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 27, 2025 | 22.60M | 40.37% |
Dec 31, 2024 | 16.10M | -35.60% |
Dec 29, 2023 | 25.00M | -72.44% |
Dec 30, 2022 | 90.70M | 27.93% |
Dec 31, 2021 | 70.90M | 43.52% |
Dec 31, 2020 | 49.40M | 68.60% |
Dec 31, 2019 | 29.30M | 79.75% |
Dec 31, 2018 | 16.30M | -51.78% |
Dec 29, 2017 | 33.80M | 37.40% |
Dec 30, 2016 | 24.60M | -7.17% |
Dec 31, 2015 | 26.50M | -66.88% |
Dec 31, 2014 | 80.00M | -34.10% |
Dec 31, 2013 | 121.40M | 68.85% |
Dec 31, 2012 | 71.90M | 315.61% |
Dec 30, 2011 | 17.30M | 7.45% |
Dec 31, 2010 | 16.10M | -26.82% |
Dec 31, 2009 | 22.00M | 19.57% |
Dec 31, 2008 | 18.40M | 9.52% |
Dec 31, 2007 | 16.80M | -69.06% |
Dec 29, 2006 | 54.30M | 3.23% |
Dec 30, 2005 | 52.60M | 107.91% |
Dec 31, 2004 | 25.30M | -13.36% |
Dec 31, 2003 | 29.20M | 14.96% |
Dec 31, 2002 | 25.40M | -33.33% |
Dec 31, 2001 | 38.10M | 495.31% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 711.28B |
Johnson & Johnson | 366.40B |
AbbVie | 327.47B |
Novo Nordisk | 301.06B |
UnitedHealth Group | 273.97B |
Abbott Laboratories | 239.05B |
Novartis AG | 231.01B |
AstraZeneca | 216.45B |